Q Chip seals encapsulation deal for peptide therapeutic
This article was originally published in Scrip
Executive Summary
Q Chip, a developer of sustained-release injectable depot formulations based in Cardiff, UK, has signed its fourth agreement this year to help a partner formulate one of its drugs. In this case, it will apply its Q-Sphera bioencapsulation techhnology to a therapeutic peptide owned by an undisclosed "leading international speciality pharmaceutical company", the firm announced.